Wuhan Mingde Bio-Tech Co., Ltd. forecasts a net loss for the first half of 2026. This is attributed to reduced government subsidies, increased bad debt provisions, and lower returns on wealth management products, resulting in a total profit decline exceeding 40 million yuan.
Summary generated by AI · Always verify with source document
Wuhan Mingde Bio-Tech Co., Ltd.
2026 Interim Performance Forecast
The Company and the Board of Directors guarantee the content of this information disclosure is true, accurate, and complete, and that there are no false records, misleading statements, or major omissions.
I. Interim Performance Forecast
Performance Forecast Period: January 1, 2026 to June 30, 2026
Performance Forecast: Net profit is expected to be negative.
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.